| Molecular Formula | C58H80Cl2N2O14 |
| Molar Mass | 1100.17 |
| Specific Rotation(α) | 20D -62.7° (c = 1.9 in water) |
| Storage Condition | Hygroscopic, -20°C Freezer, Under Inert Atmosphere |
| Physical and Chemical Properties | Amorphous solid. [Α] D20-62.7 °(C = 1.9, water). |
| In vitro study | Mivacurium induces LAD2 cell degranulation in a dose-dependent manner. Mivacurium stimulates intracellular Ca 2+ influx in MRGPRX2-HEK293 cells but not in NC-HEK293 cells. Mivacurium induces the release of only low levels of mediators in LAD2 cells transfected with MRGPRX2-targeted small interfering siRNA. |
| In vivo study | Mivacurium causes pseudo-allergic reactions in C57 wild-type mice by inducing mast cells to release histamine and a decrease in body temperature. Mivacurium is rapidly hydrolyzed in the plasma and has a short duration of action (< 10 min). Mivacurium has many advantages, such as a rapid effect, nonneurological toxicity and a lack of heart rate alteration. |
| Biological activity | Mivacurium dichloride is a benzyl isoquinoline derivative, and is also a short-acting non-depolarizing neuromuscular blocker and skeletal muscle relaxant. Mivacurium dichloride can be coupled to nAChR to reduce or inhibit the depolarizing effect of acetylcholine on the terminal discs of muscle cells. |
| use | short-acting non-polarized neuromuscular blocker, short-acting muscle relaxant. It can be used for short-term surgical procedures, and can be used as an auxiliary drug for relaxing skeletal muscle, promoting tracheal intubation and general anesthesia during mechanical ventilation. |
| Production method | 5 ', 8-dimethoxy-N-methylpapaverine and 3-chloropropanol, in the presence of sodium iodide, reflux in 2-butanone. The obtained quaternary ammonium salt and octyl -4-alkylene diacyl chloride were reacted in dichloroethane at room temperature to obtain mikuronium chloride. |